15 February 2021
CureVac has announced the European Medicines Agency (EMA) has begun a rolling submission of CVnCoV, the company’s mRNA-based Covid-19 vaccine candidate. The EMA’s rolling submission will accelerate time to potential marketing authorisation of CVnCoV.
Moderna announced that the company has received an additional order of four million doses of the Covid-19 vaccine from the Canadian Government, bringing the total commitment order to 44 million doses. Health Canada authorised Moderna’s Covid-19 vaccine for immunising people aged over 18 at the end of December 2020.
A new UK trial has found the arthritis drug tocilizumab reduces the risk of death among hospitalised Covid-19 patients. The RECOVERY trial also found that the drug helped reduce the need for ventilation support.
The US Government has exercised its option for an additional 100 million doses of the Pfizer–BioNTech Covid-19 Vaccine, bringing the total vaccine doses to 300 million . The US government is expected to pay $1.95bn for the additional vaccine doses.